Award-Winning CMUH (Taiwan) Excels at HIMSS, Leading Taiwan's Smart Healthcare Transformation

November 28, 2024 12:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

TAICHUNG, Nov. 27, 2024 /PRNewswire/ -- In HIMSS24 APAC Seoul, Healthcare Conference & Exhibition, China Medical University Hospital (CMUH) established international presence with four notable gradings: achieving the top score in the 2023 HIMSS Global Digital Health Indicator (DHI) and receiving prestigious certifications, including Infrastructure Adoption Model (INFRAM) Stage 7, Analytics Maturity Assessment Model (AMAM) Stage 6, and Digital Imaging Adoption Model (DIAM) Stage 6. This demonstrates the excellence of CMUH in smart healthcare practice and further improvement of quality patient care.

Leading Way to Smart Healthcare 4.0 – Enhancing Patient Care Through Digitalization

Under the leadership of CMUH's Superintendent Der-Yang Cho, CMUH has pioneered healthcare digitalization and has achieved notable international certifications. Superintendent Cho stated that CMUH is embracing "Smart Healthcare 4.0," which includes the development of novel mRNA-based CAR-T immunotherapy powered by AI-driven Drug Discovery, and smart healthcare systems developed in collaboration with Microsoft and Google since 2020. These innovations include the "Medical Information Revise Assistant (MIRA)" and the "Side-effects Organizing Platform with Healthcare Intelligent Assistance (SOPHIA)," designed to provide individualized smart healthcare. These advancements not only reduce the workload of healthcare professionals in CMUH but also ensure the best quality of care for patients.

Personnel, Process and Technology Development in Parallel as the Key to Digital Healthcare

CMUH established the Taiwan Smart Healthcare Pavilion to showcase "HiThings Tele-ICU," which highlights three notable smart healthcare platforms: the Intelligent Anti-Microbial System (i.A.M.S.) for sepsis and drug resistance infection, the Smart Heart Platform for acute myocardial infarction, and ARDiTeX for acute respiratory distress syndrome. These platforms enable comprehensive monitoring and care in critical care settings, collectively reducing nursing personnel's workload by more than 5,000 hours. According to Director Wen-Sheng Feng of the Digital Transformation Technology Office at CMUH, the system provides real-time monitoring of patients' physiological data and is useful in discovering the high-risk patients of acute respiratory distress syndrome. Supported by AI algorithms, the system sends timely notifications, ensuring prompt care and effectively reducing mortality rates by 18.9%. CMUH's Chief Secretary, Dr. Wei-Cheng Chen, highlighted that AI-driven predictions and integrated information systems empower physicians to analyze large datasets efficiently and coordinate timely interventions with multidisciplinary teams, ensuring optimal, personalized care for each patient.

Overcoming Challenges in Data Integration and Interoperability to Propel Smart Healthcare Development

Dr. Shih-Sheng Chang, Director of CMUH's AI Center, and Prof. Chi-Heum Cho, Vice Superintendent of Keimyung University Dongsan Medical Center, discussed over "The Power of Data in Modern Healthcare." Dr. Chang emphasized that data integration and interoperability remain key challenges in advancing smart healthcare. He highlighted that individualized nursing, wearable devices for real-time data collection, and AI-assisted remote surgeries are critical dimensions for unlocking the full potential of healthcare data. Dr. Chang also underscored the importance of multidisciplinary and cross-border collaborations in driving progress in this field. Meanwhile, Prof. Cho shared insights from South Korea, where a resident doctors' strike prompted hospitals to fully adopt smart technologies, including robotic delivery systems and smart operating rooms. These advancements have significantly enhanced operational efficiency and patient care.

With the acquisition of EMRAM Stage 7 re-certification, INFRAM Stage 7, AMAM Stage 6, and DIAM Stage 6 certifications, CMUH positions as a leading digital healthcare provider among Taiwan-based institutions. CMUH remains committed to fostering cross-border collaborations and enhancing patient care through the advanced application of data and AI technology. By embracing highly accurate smart healthcare solutions, CMUH continues to realize its vision of "patient-centered" care.

The Taiwan CMUH team attended HIMSS24 APAC Seoul to receive prestigious certifications. CMUH will continue advancing smart healthcare by integrating global technologies to deliver innovative treatments and improve patient care.
The Taiwan CMUH team attended HIMSS24 APAC Seoul to receive prestigious certifications. CMUH will continue advancing smart healthcare by integrating global technologies to deliver innovative treatments and improve patient care.

CONTACT: Carolyn Chen, [email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.